Next Generation Sequencing is over 20 years old, yet it is harder than ever to navigate the market.
With new players and new chemistries, researchers now have a powerful arsenal of tools available to them. Yet, understanding these tools is challenging enough, let alone the challenge of deciding which one to use.
Our latest webinar series – Sequencing: A State of Play – addresses this challenge head on. If you have questions about sequencing, or are looking for tips, tricks and lessons learned for the latest sequencing methods, you won’t want to miss this one.
Register to the Sequencing: A State of Play webinar here
**Please note that by registering for one webinar in the series, you will automatically be registered to all subsequent webinars**
Over the next three Thursdays (12th, 19th and 26th September 2024 at 3pm BST / 4pm CET / 10am EDT), 7 experts across 3 webinars will collectively build an up-to-date picture of sequencing (as of September 2024).
This webinar series will provide you with:
- An enhanced understanding of what technologies are available on the market today, how they work, and their strengths and weaknesses
- A thorough examination of when to use long and short-read sequencing, and how to handle the costs of high throughput NGS
- A sneak-peek into the future – what will it look like as the cost of sequencing continues to fall and new players enter the scene.
Webinar 3: Getting to the Long and Short of It (Panel Debate)
Thursday 26th September at 3pm BST / 4pm CET / 10am EDT
Get ready for the ultimate debate of when to use long or short-read sequencing. Webinar 3 brings together three experienced long-read and short-read adopters as they hash out the long-read/short-read debate. Will long-read replace short-read? Bring your questions to webinar 3 to find out what the experts think.
Panellists:
- Miten Jain, Associate Professor, Northwestern University
- Elsa Molina, Director, Next Generation Sequencing & Genomics Core, Salk Institute
- More speakers to be announced shortly
You will leave this webinar with:
- Answers to your questions about long-read and short-read technology
- An understanding of the additional considerations that long-read data analysis demands
- Exposure to what early-adopters are saying about the utility of the latest short-read and long-read tech
Thursday 12th September at 3pm BST / 4pm CET / 10am EDT
Webinar 1 eases you into the series by getting back to some of the basics. This webinar is an excellent opportunity to hear about the fundamentals of sequencing, with a review of the different chemistries and the considerations for choosing between them.
Talks:
An Introduction to Sequencing
- Niall Lennon, Senior Director, Genomics Platform, Broad Institute
Considering Platform Choice For Sequencing Experiments
- Claire Bailey Hartmann, Director of Bauer Core Facilities, Harvard University
You will leave this webinar with:
- An understanding of the changing sequencing landscape as of 2024
- An education on the essentials you should know about the major technologies
- Practical advice for choosing the right platform from that landscape
Webinar 2: Getting the Most Out of Your Sequencing Experiments
Thursday 19th September at 3pm BST / 4pm CET / 10am EDT
Webinar 2 gets into the nitty gritty of sequencing and is rich in tips and tricks from three leading sequencing professionals from around the globe. How do you get the most out of your samples and generate the best quality data downstream? Webinar 2 has your answers.
Talks:
Sequencing Success – Expert Tips and Techniques
- Elsa Molina, Director, Next Generation Sequencing & Genomics Core, Salk Institute
From Sample to Sequencing Success – How To Deal With Difficult Samples
- Sally James, Head of Genomics, University of York
Lessons Learned from Early Adoption of New Short-Read Sequencers
- Michael Peterson, Scientist I, Stowers Institute for Medical Research
You will leave this webinar with:
- Knowledge of the essentials for effective sample and library prep
- Practical advice for dealing with difficult samples and how improper sample prep limits sequencing potential
- Advice on the financials of investing and running a sequencer
- Lessons learned from beta-testing and working with new chemistries
